MSB 2.10% $1.17 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-88

  1. 15,455 Posts.
    lightbulb Created with Sketch. 5536
    As the thread title states - RWE or Real World Evidence of why Mesoblast are looking to run an additional phase 3 COVID-19 ARDS trial .... here are the last two days of COVID-19 deaths in the USA alone where all the latest and if you believe some on here greatest treatments are available ?


    I continually ask the question - why are so many people still dying each day if the current regime of drugs and treatments are working ? ~2,000 people dying per day in the USA is just ridiculous IMO this far into this pandemic and it is really quite sad


    Many MSC trials have shown positive results in treating COVID-19 ARDS around the world ... time for someone to fund this additional Remestemcel-L phase 3 trail for COVID-19 ARDS me thinks !


    https://www.worldometers.info/coronavirus/

    Thursday 20th Jan
    upload_2022-1-21_11-31-31.png


    Wednesday 19th Jan
    upload_2022-1-21_11-30-9.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.